SOURCE: Dynavax Technologies

Dynavax Technologies

March 03, 2011 09:00 ET

Dynavax to Present at the Cowen Healthcare Conference

BERKELEY, CA--(Marketwire - March 3, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the Cowen and Company 31st Annual Health Care Conference in Boston on Tuesday, March 8, 2011 at 9:30 am EST (6:30 am PST) at the Boston Marriott Copley Place.

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at http://investors.dynavax.com/newsevents.cfm

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to enhance protection more rapidly with fewer doses than current licensed vaccines. For more information visit www.dynavax.com.

Contact Information

  • Contact:
    Shari Annes
    Investor Relations
    510-665-7211
    Email Contact